PAR1 and PAR2 are KLK4 substrates, expressed in both malignant and nonmalignant prostate cells, and involved in PCa progression (Ramsay et al., 2008a,b; Wang et al., 2010). The gene discussed is KLK4; the disease is posterior cortical atrophy.